Zhili Wen

598 total citations
25 papers, 289 citations indexed

About

Zhili Wen is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, Zhili Wen has authored 25 papers receiving a total of 289 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Epidemiology and 7 papers in Hepatology. Recurrent topics in Zhili Wen's work include RNA modifications and cancer (5 papers), Hepatitis B Virus Studies (5 papers) and Liver Disease Diagnosis and Treatment (4 papers). Zhili Wen is often cited by papers focused on RNA modifications and cancer (5 papers), Hepatitis B Virus Studies (5 papers) and Liver Disease Diagnosis and Treatment (4 papers). Zhili Wen collaborates with scholars based in China, United States and United Kingdom. Zhili Wen's co-authors include Hao Ding, Qian Yang, Kai Xiong, Zhihua Xiao, Wei Huang, Meiping Zhang, Kegui Zhang, Zhijun Luo, Xiaohua Yan and Hao Jiang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Zhili Wen

22 papers receiving 284 citations

Peers

Zhili Wen
Comparison fields: 5 of 56
  • Molecular Biology 166
  • Cancer Research 103
  • Hepatology 77
  • Epidemiology 72
  • Oncology 38
Replace Rui Cong with:
Rui Cong China
Zhipeng Cao Australia
A Chikamoto Japan
Ram C. Shankaraiah Italy
Francesca Garibaldi Italy
Viktoria Kalna United Kingdom
Mengyi Shen China
Léa Meunier France
Hiromi Chikada Japan
Jingxiong Hu China
Rui Cong China View profile →
Citations per field, relative to Zhili Wen
Zhili Wen · 1×
Citations per year, relative to Zhili Wen
Zhili Wen · 1×

Countries citing papers authored by Zhili Wen

Since Specialization
Citations

This map shows the geographic impact of Zhili Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhili Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhili Wen more than expected).

Fields of papers citing papers by Zhili Wen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhili Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhili Wen. The network helps show where Zhili Wen may publish in the future.

Co-authorship network of co-authors of Zhili Wen

This figure shows the co-authorship network connecting the top 25 collaborators of Zhili Wen. A scholar is included among the top collaborators of Zhili Wen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhili Wen. Zhili Wen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 0
2 0
3 1
4 2
5 1
6 1
7
Exosomes with IR780 and Lenvatinib loaded on GPC3 single-chain scFv antibodies for targeted hyperthermia and chemotherapy in hepatocellular carcinoma therapy.
5
8 1
9 0
10 6
11 69
12 4
13 8
14 6
15 33
16 4
17 16
18 7
19 8
20 6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026